J Korean Geriatr Soc.  2015 Dec;19(4):241-243. 10.4235/jkgs.2015.19.4.241.

The Effects of Zolpidem on Akinesia in a Parkinson Disease Patient: A Case Report

Affiliations
  • 1Department of Neurology, Kosin University College of Medicine, Busan, Korea. merritt329@hanmail.net

Abstract

Zolpidem, an imidazopyridine drug that affects the gamma-aminobutyric acid receptor, is typically used as a hypnotic sedative. It has been reported that this drug improves motor symptoms in patients with various movement disorders, including Parkinson disease. We presented a patient with advanced Parkinson disease who demonstrated improved akinesia after taking zolpidem without sleep induction or consciousness changes.

Keyword

Zolpidem; Gamma-aminobutyric acid; Parkinson disease

MeSH Terms

Consciousness
gamma-Aminobutyric Acid
Humans
Movement Disorders
Parkinson Disease*
Receptors, GABA
Receptors, GABA
gamma-Aminobutyric Acid
Full Text Links
  • JKGS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr